Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with Cisplatin
暂无分享,去创建一个
A. Friggeri | C. Rioufol | O. Glehen | L. Villeneuve | N. Bakrin | V. Kepenekian | F. Ranchon | W. Gertych | Naoual Bakrin | N. Laplace | O. Vassal | Arnaud Friggeri
[1] R. Bellomo,et al. Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine (StEP) initiative: renal endpoints , 2018, British journal of anaesthesia.
[2] B. Morland,et al. Sodium Thiosulfate for Protection from Cisplatin‐Induced Hearing Loss , 2018, The New England journal of medicine.
[3] L. Fleisher,et al. Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine (StEP) initiative: patient comfort , 2018, British journal of anaesthesia.
[4] N. Aaronson,et al. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer , 2018, The New England journal of medicine.
[5] K. Soo,et al. Acute kidney injury in ovarian cancer patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy , 2017, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[6] B. Souweine,et al. Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies) , 2016, Annals of Intensive Care.
[7] B. Souweine,et al. Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies). , 2016, Anaesthesia, critical care & pain medicine.
[8] E. Decullier,et al. Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility? , 2016, Annals of Surgical Oncology.
[9] A. Azzam,et al. The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery , 2014, Renal failure.
[10] C. Pomel,et al. Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer. , 2014, Journal of visceral surgery.
[11] S. Msika,et al. Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[12] R. Rodby,et al. Unexpectedly Severe Metabolic Acidosis Associated with Sodium Thiosulfate Therapy in a Patient with Calcific Uremic Arteriolopathy , 2011, Seminars in dialysis.
[13] S. Msika,et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy , 2010, Cancer.
[14] E. Cotte,et al. Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Recurrent Endometrial Carcinoma Confined to the Peritoneal Cavity , 2010, International Journal of Gynecologic Cancer.
[15] T. Chua,et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] W. Richards,et al. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. , 2009, The Journal of thoracic and cardiovascular surgery.
[17] Lingyun Ji,et al. Sodium Thiosulfate Administered Six Hours after Cisplatin Does Not Compromise Antineuroblastoma Activity , 2008, Clinical Cancer Research.
[18] F. Grosso,et al. Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Systemic Toxicity , 2007, Annals of Surgical Oncology.
[19] A. Hall,et al. Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning? , 2007, Annals of emergency medicine.
[20] F. Roviello,et al. Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemoperfusion (IHCP): Postoperative Outcome and Risk Factors for Morbidity , 2006, World Journal of Surgery.
[21] F. Lombardo,et al. Extravasation of chemotherapeutic agents: prevention and treatment. , 2006, Seminars in oncology.
[22] E. Neuwelt,et al. Protection against Cisplatin-Induced Toxicities by N-Acetylcysteine and Sodium Thiosulfate as Assessed at the Molecular, Cellular, and in Vivo Levels , 2005, Journal of Pharmacology and Experimental Therapeutics.
[23] D. Spector,et al. Successful treatment of calciphylaxis with intravenous sodium thiosulfate. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] F. Gilly,et al. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. , 2004, The Lancet. Oncology.
[25] E. Cotte,et al. Intraperitoneal Chemohyperthermia Using a Closed Abdominal Procedure and Cytoreductive Surgery for the Treatment of Peritoneal Carcinomatosis: Morbidity and Mortality Analysis of 216 Consecutive Procedures , 2003, Annals of Surgical Oncology.
[26] S. Antoun,et al. Complications et tolérance de la chimio-hyperthermie intrapéritonéale (CHIP) après exérèse chirurgicale des carcinoses péritonéales (CP) : résultats d'une étude de phase I-II portant sur des CP de différentes origines , 2000 .
[27] M. Ducreux,et al. [Complications and tolerance of heated intraperitoneal chemotherapy and cytoreductive surgery for peritoneal carcinomatosis: results of a phase I-II study of peritoneal carcinomatosis from different sources]. , 2000, Bulletin du Cancer.
[28] R. Verheijen,et al. Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual disease. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.
[29] O. Dalesio,et al. Phase II trial for intraperitoneal cisplatin plus intravenous sodium thiosulphate in advanced ovarian carcinoma patients with minimal residual disease after cisplatin-based chemotherapy--a phase II study of the EORTC Gynaecological Cancer Cooperative Group. , 1994, European journal of cancer.
[30] O. Tanizawa,et al. Neutralizing effect of sodium thiosulfate on antitumor efficacy of cisplatin for human carcinoma xenografts in nude mice. , 1991, Gynecologic oncology.